(6R)-6-(Hydroxymethyl)morpholin-3-one, 98+%, 5g

(S)-(+)-NBD-APy [=(S)-(+)-4-Nitro-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination]100mg

N-(1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)acetamide, 95%, 25g

4,5-Dibromopyridin-2-amine, 95.0%, 5g

2-Chloro-1-(3-hydroxyazetidin-1-yl)ethan-1-one, 95.0%, 10g

N-Acetyl-epsilon-caprolactam>98.0%(GC)25g

1-DIFLUOROMETHYL-2-OXO-1,2-DIHYDRO-PYRIDINE-3-CARBOXYLIC ACID, 95.0%, 10g

5-Aminomethylfuroic acid, 95.0%, 250mg

4-Bromo-5-fluoro-1-methylpyridin-2(1H)-one, 97%, 1g

2-(cyclopropylmethyl)hexahydrocyclopenta[c]pyrrole-3a(1H)-carboxylic acid, 95.0%, 1g

(2-Bromooxazol-4-yl)methanol, 95.0%, 250mg

4-Bromo-2-ethylpyridine, 95.0%, 250mg

5-(2-chlorophenyl)-1,3,4-thiadiazol-2-amine, 95.0%, 5g